Table 2.
OLS regression results of attributes on booster acceptance.
| (1) | (2) | |
|---|---|---|
| Efficacy: 70% | 0.103*** (0.024) |
0.099*** (0.023) |
| Efficacy: 90% | 0.237*** (0.024) |
0.231*** (0.024) |
| Duration: 1 year | 0.048** (0.022) |
0.042* (0.022) |
| Duration: 2 years | 0.035 (0.023) |
0.037 (0.023) |
| Protection: Protects against future variants | 0.043** (0.018) |
0.038** (0.017) |
| Manufacturer: Moderna | −0.051** (0.024) |
−0.050** (0.024) |
| Manufacturer: Johnson & Johnson | −0.178*** (0.023) |
−0.176*** (0.023) |
| Incentive: Paid day off work | 0.031 (0.027) |
0.037 (0.027) |
| Incentive: $100 incentive | 0.085*** (0.028) |
0.092*** (0.028) |
| Incentive $1000 incentive | 0.164*** (0.027) |
0.175*** (0.026) |
| Likely more contagious, less lethal treatment | 0.076*** (0.029) |
0.074*** (0.028) |
| Controls | ||
| Democrat | 0.070* (0.038) |
|
| Republican | −0.086** (0.040) |
|
| Female | −0.031 (0.028) |
|
| Age (in 10s) | −0.033*** (0.010) |
|
| Black | −0.069 (0.050) |
|
| Latino | −0.020 (0.049) |
|
| Education | 0.010 (0.010) |
|
| Income | 0.007 (0.010) |
|
| Work from home | −0.076* (0.045) |
|
| Work in-person, remote capable | −0.064 (0.054) |
|
| Work in-person, essential | −0.057 (0.037) |
|
| Constant | 0.407*** (0.036) |
0.494*** (0.088) |
| Observations | 2740 | 2740 |
| R-squared | 0.090 | 0.121 |
Note: ***p < 0.01, **p < 0.05, *p < 0.1. OLS regressions on willingness to receive booster among fully vaccinated, but non-boosted respondents. Base categories for each attribute are: Efficacy-50%; Protection duration-6 months; Future variants: May require a booster against future variants; Manufacturer-Pfizer; Incentive-$10. The dependent variable in these regressions is a binary variable indicating willingness to receive a hypothetical vaccine booster. Robust standard errors in parentheses.